These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16284529)

  • 1. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.
    Nunes D; Fleming C; Offner G; O'Brien M; Tumilty S; Fix O; Heeren T; Koziel M; Graham C; Craven DE; Stuver S; Horsburgh CR
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):538-44. PubMed ID: 16284529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
    Kliemann DA; Wolff FH; Tovo CV; Alencastro PR; Ikeda ML; Brandão AB; Barcellos N; Fuchs SC
    Ann Hepatol; 2016; 15(1):27-32. PubMed ID: 26626637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice.
    Macías J; González J; Ortega E; Tural C; Cabrero E; Burgos A; Pineda JA;
    HIV Med; 2010 Aug; 11(7):439-47. PubMed ID: 20180868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
    Derbala M; Elbadri ME; Amer AM; AlKaabi S; Sultan KH; Kamel YM; Elsayed EH; Avades TY; Chandra P; Shebl FM
    World J Gastroenterol; 2015 Dec; 21(46):13132-9. PubMed ID: 26674154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
    Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
    J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
    Abdel-Hameed EA; Rouster SD; Kottilil S; Sherman KE
    Clin Infect Dis; 2021 Aug; 73(3):450-459. PubMed ID: 32459305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive markers for staging fibrosis in chronic delta hepatitis.
    Takyar V; Surana P; Kleiner DE; Wilkins K; Hoofnagle JH; Liang TJ; Heller T; Koh C
    Aliment Pharmacol Ther; 2017 Jan; 45(1):127-138. PubMed ID: 27813124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
    Al-Mohri H; Murphy T; Lu Y; Lalonde RG; Klein MB
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):463-9. PubMed ID: 17211282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.
    Jain MK; Seremba E; Bhore R; Dao D; Joshi R; Attar N; Yuan HJ; Lee WM
    AIDS Patient Care STDS; 2012 Feb; 26(2):73-80. PubMed ID: 22239101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of APRI score in liver disease following the introduction of antiretroviral therapy in HIV and HCV coinfected versus HIV monoinfected patients].
    Antonello VS; Tovo CV; Kliemann DA; Santos BR; Zaltron VF
    Rev Soc Bras Med Trop; 2010; 43(6):678-81. PubMed ID: 21181022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H; Cooper C; Murphy T; Klein MB
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
    Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
    Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.